封面
市场调查报告书
商品编码
1701097

生命科学分析市场规模、份额、成长分析(按组件、按类型、按应用、按交付模式、按最终用户、按地区)—2025 年至 2032 年行业预测

Life Science Analytics Market Size, Share, and Growth Analysis, By Component (Software, Services), By Type (Descriptive Analytics, Predictive Analytics), By Application, By Delivery Mode, By End-User, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2023 年生命科学分析市场规模价值 298.6 亿美元,预计将从 2024 年的 332.6 亿美元增长到 2032 年的 780.9 亿美元,预测期内(2025-2032 年)的复合年增长率为 11.4%。

生命科学分析市场预计将经历显着增长,这得益于电子健康记录、临床试验、基因组测序、可穿戴设备和社交媒体等不同来源的医疗保健数据量呈指数级增长。儘管面临资料隐私和整合等挑战,该行业也提供了重大机会,特别是透过整合人工智慧 (AI) 和机器学习 (ML) 来增强药物发现和个人化医疗。在生命科学领域,全球范围内都存在着基于证据的决策的需求,而且这种趋势正在加速。分析可以帮助开发人员推动药物开发创新、改善患者照护、提高业务效率,并利用丰富的医疗保健数据在快速发展的环境中策略性地定位自己。

目录

介绍

  • 调查目的
  • 研究范围
  • 定义

调查方法

  • 资讯采购
  • 二次资料和一次资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分机会分析

市场动态与展望

  • 市场概览
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2024年)
  • PESTEL分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究
  • 技术进步
  • 监管格局

生命科学分析市场规模(依组成部分及复合年增长率) (2025-2032)

  • 市场概览
  • 软体
    • 本地解决方案
    • 云端基础的解决方案
    • 基于SAAS的解决方案
  • 服务
    • 託管服务
    • 分析服务
    • 咨询服务
    • 专业服务
    • 培训与实施
    • 维护和支援服务
    • 其他的

生命科学分析市场规模(按类型和复合年增长率)(2025-2032)

  • 市场概览
  • 说明分析
  • 预测分析
  • 指示性分析

生命科学分析市场规模(按应用和复合年增长率)(2025-2032)

  • 市场概览
  • 研究与开发
    • 临床试验
    • 临床前和药物发现
  • 商业分析
    • 销售和行销支持
    • 市场进入
    • RWE 和价值证据
    • 参与服务
  • 监理合规
  • 製造和供应链优化
  • 安全
    • 药物警戒
    • 医疗设备安全
    • 诊断警报

生命科学分析市场规模(依交付模式和复合年增长率)(2025-2032)

  • 市场概览
  • 本地
  • 云端基础

生命科学分析市场规模(按最终用户和复合年增长率) (2025-2032)

  • 市场概览
  • 製药和生物技术公司
  • 医疗设备公司
  • 研究中心
  • 第三方管理员
  • 其他的

生命科学分析市场规模(按地区)及复合年增长率(2025-2032)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024年)
  • 主要企业简介
    • 公司详情
    • 产品系列分析
    • 公司分部份额分析
    • 收益与前一年同期比较对比(2022-2024 年)

主要企业简介

  • Accenture(Ireland)
  • Cognizant(USA)
  • IBM Corporation(USA)
  • MaxisIT(USA)
  • Oracle Corporation(USA)
  • IQVIA(USA)
  • SAS Institute Inc.(USA)
  • EXL Service(Scioinspire Corp.)(USA)
  • Take Solutions Limited(India)
  • Wipro Limited(India)
  • Dynata(USA)
  • M3(EU)Ltd(UK)
  • Serma Group(France)
  • Apollo Intelligence(USA)
  • Allscripts Healthcare Solutions(USA)
  • Cerner Corporation(USA)
  • Optum(USA)
  • Microsoft(USA)
  • Infosys Limited(India)

结论和建议

简介目录
Product Code: SQMIG35G2221

Life Science Analytics Market size was valued at USD 29.86 Billion in 2023 and is poised to grow from USD 33.26 Billion in 2024 to USD 78.09 Billion by 2032, growing at a CAGR of 11.4% during the forecast period (2025-2032).

The life science analytics market is poised for substantial growth, propelled by the escalating volume of healthcare data generated from diverse sources like electronic health records, clinical trials, genomic sequencing, wearables, and social media. Despite facing challenges such as data privacy and integration, the sector presents remarkable opportunities, particularly through the integration of artificial intelligence (AI) and machine learning (ML) to enhance drug discovery and personalized medicine. The global demand for evidence-based decision-making in life sciences further fuels this trend. Organizations can harness analytics to drive innovation in drug development, elevate patient care, and improve operational efficiency, positioning themselves strategically in this rapidly evolving landscape by leveraging the wealth of healthcare data available.

Top-down and bottom-up approaches were used to estimate and validate the size of the Life Science Analytics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Life Science Analytics Market Segments Analysis

The global life science analytics market is segmented based on type, component, delivery, application, end-user and region. Based on type, the market is segmented into descriptive, predictive, and prescriptive. Based on component, the market is segmented into software, and services. In terms of delivery, the market is segmented into on-premise model, and on-demand model. Based on application, the market is segmented into research & development, preclinical trials, clinical trials, sales & marketing, regulatory compliance, supply chain optimization, pharmacovigilance. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, medical device companies, research centers, and third-party administrators. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Life Science Analytics Market

The increasing use of real-world data, such as electronic health records, wearable devices, and social media interactions, is significantly fueling the demand for analytics solutions in the Life Science Analytics market. This type of data offers critical insights into patient outcomes, the effectiveness of treatments, and overall population health trends. By leveraging these insights, stakeholders in the life sciences industry can make informed, evidence-based decisions that enhance patient care and optimize health outcomes. The shift towards data-driven approaches is thus pivotal in transforming the landscape of life sciences, prompting a growing need for advanced analytics capabilities.

Restraints in the Life Science Analytics Market

The Life Science Analytics market faces significant challenges due to the handling of sensitive patient information, which raises critical issues surrounding data privacy and security. Stringent regulations and compliance mandates, such as the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA), complicate data governance for organizations. Navigating these legal frameworks is essential to ensure the protection of patient confidentiality, but it can also create logistical hurdles and increased operational costs. As companies strive to adhere to these regulations, they may encounter difficulties that hamper innovation and slow down the overall growth of the market.

Market Trends of the Life Science Analytics Market

The Life Science Analytics market is experiencing a pronounced trend towards real-time analytics, significantly transforming decision-making processes within the industry. As organizations strive for agility in an increasingly dynamic environment, the demand for real-time data integration, processing, and analysis is intensifying. This shift is particularly evident in sectors like personalized medicine, where timely insights can enhance treatment outcomes, and in patient monitoring, which necessitates immediate data-driven responses. Furthermore, supply chain optimization is being revolutionized by real-time insights, allowing firms to adapt swiftly to fluctuations in demand and improve operational efficiency. Thus, the ability to harness real-time analytics is becoming a critical competitive differentiator in the life sciences landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Technology Advancement
  • Regulatory Landscape

Global Life Science Analytics Market Size by Component & CAGR (2025-2032)

  • Market Overview
  • Software
    • On-Premise Solutions
    • Cloud-Based Solutions
    • SAAS-Based Solutions
  • Services
    • Managed Services
    • Analytical Services
    • Consulting Services
    • Professional Services
    • Training & Implementation
    • Maintenance & Support Services
    • Other

Global Life Science Analytics Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics

Global Life Science Analytics Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Research and Development
    • Clinical Trials
    • Preclinical & Drug Discovery
  • Commercial Analytics
    • Sales & Marketing Support
    • Market Access
    • RWE & Value Evidence
    • Engagement Services
  • Regulatory Compliance
  • Manufacturing & Supply Chain Optimization
  • Safety
    • Pharmacovigilance
    • Medical Device Safety
    • Diagnostic Vigilance

Global Life Science Analytics Market Size by Delivery Mode & CAGR (2025-2032)

  • Market Overview
  • On-Premises
  • Cloud-Based

Global Life Science Analytics Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Research Centers
  • Third-Party Administrators
  • Others

Global Life Science Analytics Market Size & CAGR (2025-2032)

  • North America (Component, Type, Application, Delivery Mode, End-User)
    • US
    • Canada
  • Europe (Component, Type, Application, Delivery Mode, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Component, Type, Application, Delivery Mode, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Component, Type, Application, Delivery Mode, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Component, Type, Application, Delivery Mode, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Accenture (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cognizant (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IBM Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MaxisIT (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oracle Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IQVIA (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SAS Institute Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EXL Service (Scioinspire Corp.) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Take Solutions Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wipro Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dynata (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • M3 (EU) Ltd (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Serma Group (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Apollo Intelligence (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allscripts Healthcare Solutions (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cerner Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Optum (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Microsoft (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Infosys Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations